OHSU researchers collaborate on potential ‘game-changer’ for people with multiple sclerosis.

Researchers at Oregon Health & Science University are challenging the convention that tetanus and diphtheria vaccine boosters need to be administered every 10 years. Their paper in Clinical Infectious Diseases recommends that the current adult ...

Native structure of a receptor may lead to finding the mechanism behind conditions like Alzheimer’s disease.

Study indicates that a common class of antidepressants may worsen tinnitus.

'It's clear to me that OHSU is a special place," says OHSU's President-select, Dr. Danny Jacobs.

A machine-learning algorithm can predict long-term brain impact, and may identify early treatment opportunities for children.

Research published online in the journal Endocrinology found that a small synthetic molecule initially developed to lower cholesterol may slow or stop the devastating progression of the neurodegenerative disease adrenoleukodystrophy, or ALD. The study was conducted in a mouse model, but planning is under way for a human clinical trial.

State-of-the-art cancer research facility will support a collaborative atmosphere, bring multidisciplinary scientists together under one roof.

OHSU study indicates clinical outcomes for deep brain stimulation while patients are asleep are on par or better than surgery while awake.

Cells and platelets stick inside arteries, increasing risk after the initial heart attack.